Many BDSC stocks contain patented components. The most common of these are listed below, but this list is not exhaustive. Patent owners permit unrestricted use of their materials for nonprofit research only. It is the recipient's responsibility to obtain any necessary licenses from the patent holder for commercial work with these stocks.
The U.S. Patent and Trademark Office (PTO) offers a searchable full-text database of U.S. patents issued since January 1, 1976. Use the PTO search page to find many patents related to Drosophila. FlyBase also includes Drosophila patents in its references, but only the citation is available from FlyBase.
Report of the National Institutes of Health (NIH) Working Group on Research Tools
- Full report
- Basic Guidelines for the Transfer of Research Tools to and from Recipients of NIH Funds
Patents and Licenses of Particular Relevance to Drosophila Researchers
- United States Patent Number 4,670,388, Method of incorporating DNA into genome of Drosophila
- United States Patent Number 5,348,874, 5,840,865, 6,159,717, 6,469,228, Eukaryotic transposable element
- United States Patent Number 5,641,673, Cell ablation using trans-splicing ribozymes
- United States Patent Number 6,124,128, Long wavelength engineered fluorescent proteins
- United States Patent Application Number 20110111445, Peptide for determining actin structures in living cells
- United States Patent Number 8,697,359, CRISPR-Cas systems and methods for altering expression of gene products
- United States Patent Number 4,959,317, Site-specific recombination of DNA in eukaryotic cells
- Memorandum of Understanding between Dupont and the PHS
- Any use of Exelixis, Inc. stocks for commercial research requires a separate use license. Please visit this page for licensing information.